Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Kashiv BioSciences LLC today announced that it has entered into an exclusive licensing agreement for ADL a proposed biosimilar to omalizumab referencing
Ovid Therapeutics Inc a biopharmaceutical company dedicated to improving the lives of people affected by rare epilepsies
Biophytis SA a clinicalstage biotechnology company specialized in the development of therapeutics for agerelated diseases presented the rollout and results of its phase COVA
Idorsia Ltd announced today that the European Commission has approved JERAYGO for the treatment of resistant hypertension in adult patients in combination with at least three antihypertensive medicinal products
